Mechanisms underlying the relaxation by A484954, a eukaryotic elongation factor 2 kinase inhibitor, in rat isolated mesenteric artery

J Pharmacol Sci. 2018 May;137(1):86-92. doi: 10.1016/j.jphs.2018.04.006. Epub 2018 May 2.

Abstract

Eukaryotic elongation factor 2 kinase (eEF2K) is a calmodulin-related protein kinase which regulates protein translation. A484954 is an inhibitor of eEF2K. In the present study, we investigated the acute effects of A484954 on contractility of isolated blood vessels. Isometric contraction of rat isolated aorta and main branch of superior mesenteric artery (MA) was measured. Expression of an inward rectifier K+ (Kir) channel subtype mRNA and protein was examined. A484954 caused relaxation in endothelium-intact [E (+)] and -denuded [E (-)] aorta or MA precontracted with noradrenaline (NA). The relaxation was higher in MA than aorta. The relaxation was partially inhibited by a nitric oxide (NO) synthase inhibitor, NG-nitro-l-arginine methyl ester (300 μM) in E (+) MA. The relaxation was significantly smaller in MA precontracted with high K+ than NA. The A484954-induced relaxation was significantly inhibited by a Kir channel blocker, BaCl2 (1 mM) compared with vehicle control in E (-) MA. Expression of Kir2.2 mRNA and protein was significantly higher in MA than aorta. We for the first time revealed that A484954 induces relaxation through opening smooth muscle Kir (Kir2.2) channel and through endothelium-derived NO in MA.

Keywords: Blood vessel; K(+) channel; Vascular smooth muscle; Vasorelaxation.

MeSH terms

  • Animals
  • Cyclopropanes / pharmacology*
  • Elongation Factor 2 Kinase / antagonists & inhibitors*
  • Elongation Factor 2 Kinase / physiology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Enzyme Inhibitors / pharmacology*
  • In Vitro Techniques
  • Isometric Contraction / drug effects*
  • Male
  • Mesenteric Artery, Superior / drug effects*
  • Muscle Contraction / drug effects
  • Muscle Relaxation / drug effects*
  • Muscle, Smooth, Vascular / drug effects*
  • Nitric Oxide / metabolism
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Protein Biosynthesis / genetics
  • Protein Biosynthesis / physiology
  • Pyridines
  • Pyrimidines / pharmacology*
  • Pyrrolidines / pharmacology*
  • Rats, Wistar

Substances

  • A-484954
  • Cyclopropanes
  • Enzyme Inhibitors
  • Kir2.2 channel
  • Potassium Channels, Inwardly Rectifying
  • Pyridines
  • Pyrimidines
  • Pyrrolidines
  • Nitric Oxide
  • Elongation Factor 2 Kinase